ABBOTT LABORATORIES 4
4 · ABBOTT LABORATORIES · Filed Mar 2, 2010
Insider Transaction Report
Form 4
LIEPMANN HOLGER A
Executive Vice President
Transactions
- Sale
Common shares without par value
2010-02-26$54.33/sh−4,995$271,378→ 174,978 total - Sale
Common shares without par value
2010-02-26$54.33/sh−1,100$59,764→ 185,773 total - Sale
Common shares without par value
2010-02-26$54.33/sh−1,000$54,333→ 181,473 total - Sale
Common shares without par value
2010-02-26$54.33/sh−200$10,866→ 185,573 total - Sale
Common shares without par value
2010-02-26$54.33/sh−100$5,433→ 185,473 total - Sale
Common shares without par value
2010-02-26$54.33/sh−500$27,165→ 180,973 total - Sale
Common shares without par value
2010-02-26$54.32/sh−800$43,456→ 179,973 total - Sale
Common shares without par value
2010-02-26$54.31/sh−400$21,724→ 169,275 total - Tax Payment
Common shares without par value
2010-02-26$54.12/sh−11,469$620,702→ 186,873 total - Sale
Common shares without par value
2010-02-26$54.33/sh−3,000$162,993→ 182,473 total - Sale
Common shares without par value
2010-02-26$54.33/sh−200$10,866→ 180,773 total - Sale
Common shares without par value
2010-02-26$54.31/sh−500$27,155→ 174,478 total - Sale
Common shares without par value
2010-02-26$54.31/sh−4,803$260,851→ 169,675 total
Holdings
- 14,752(indirect: By Trust)
Common shares without par value
- 296(indirect: By Spouse)
Common shares without par value
- 295(indirect: By Spouse)
Common shares without par value
Footnotes (2)
- [F1]Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2010.
- [F2]The reporting person disclaims beneficial ownership of all securities held by his daughters.